Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bausch + Lomb Reports enVista Envy Intraocular Lens Met All Primary Efficacy And Safety Endpoints In Multicenter US Study

Author: Benzinga Newsdesk | September 11, 2025 06:04am

enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study
Results show that enVista Envy IOLs deliver excellent visual performance, good contrast sensitivity and a favorable dysphotopsia profil

Posted In: BLCO